跳至主要内容
临床试验/ACTRN12610000565044
ACTRN12610000565044尚未招募2 期

Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicals in Mediterranean and Middle eastern Males suffering from Type 2 Diabetes with diabetic foot syndrome.

CamMedica, Ltd.0 个研究点目标入组 35 人开始时间: 2010年7月13日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
Male

入选标准

  • Mediterranean and Middle Eastern males, age 18-65 (inclusive) suffering from Type 2 Diabetes with diabetic foot syndrome (1 and 2 grade Wagner scale) with body weight between 60-80 kg.
  • Stable metabolic and glycemic control during last three months of disease and during trial period.
  • Foot ulcer aged at least two weeks sized 0.5-2.0 cm.

排除标准

  • Any foot ulceration not related to type 2 diabetes
  • Diabetic foot syndrome graded above 2 on Wagner's scale.
  • Kidney abnormalities requiring medical intervention.
  • Infectious complications of diabetic foot syndrome.
  • Critical abnormalities of blood circulation in affected limb.

研究者

发起方
CamMedica, Ltd.

相似试验